<DOC>
	<DOCNO>NCT01023282</DOCNO>
	<brief_summary>The study evaluate safety tolerability ACR325 Parkinson disease patient evaluate effect levodopa induce dyskinesia .</brief_summary>
	<brief_title>Safety Tolerability Study Evaluating ACR325 Parkinson 's Disease Patients</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<criteria>Diagnosis idiopathic Parkinsonâ€Ÿs disease accord United Kingdom Parkinson 's Disease Society brain bank diagnostic criterion Levodopa induce dyskinesia Previous surgery Parkinson 's disease Any current history heart condition increase proarrhythmic risk Severe ongoing unstable medical condition</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Parkinson 's disease</keyword>
	<keyword>Levodopa</keyword>
	<keyword>Dyskinesia</keyword>
	<keyword>ACR325</keyword>
</DOC>